Additional research has yielded intriguing discoveries, indicating that PtdSer enhances the efficiency of PD-L1 signalling in T cells and thus verifying the existence of a PtdSer-TAM-PD-L1 axis in breast cancer. This evidence concerns the gene CD274 and breast carcinoma.